Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone for Postoperative Atrial Fibrillation
NCT02715687Phase 3Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Amiodarone with Placebo (2 arms). Primary endpoint: Postoperative atrial fibrillation at 30 days. Status: unknown.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02715687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715687.